Eli Lilly and Company (LLY) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)Seeking Alpha • 09/11/23
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billionCNBC • 09/09/23
Only 2 Mega-Cap Monster Stocks Have Risen in Each of the Last 5 Years: Are They Buys Now?The Motley Fool • 09/09/23
The economic cost of obesity is expected to soar to $4 trillion by 2035. Weight loss drugs like Ozempic could change that, Goldman Sachs says.Business Insider • 09/08/23
Is Eli Lilly Stock A Buy Now That It Has Hit A Profit-Taking Zone?Investors Business Daily • 09/08/23
Drug And Tech Services Stocks Surge To New Highs, Buy Zones With Strong Technical RatingsInvestors Business Daily • 09/08/23
Here's 1 Stock That Could Join Apple and Amazon in the $1 Trillion Club That You Might Have OverlookedThe Motley Fool • 09/05/23
Novo Nordisk Is Now Europe's Biggest Company, Driven by Weight-Loss Drug. How Eli Lilly Could Benefit.Barrons • 09/05/23
Medicare's First Price Negotiation List Targets Expensive Drugs (Revised)Zacks Investment Research • 08/31/23